These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20488256)

  • 1. Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects.
    Naylor JC; Kilts JD; Hulette CM; Steffens DC; Blazer DG; Ervin JF; Strauss JL; Allen TB; Massing MW; Payne VM; Youssef NA; Shampine LJ; Marx CE
    Biochim Biophys Acta; 2010 Aug; 1801(8):951-9. PubMed ID: 20488256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease.
    Marx CE; Trost WT; Shampine LJ; Stevens RD; Hulette CM; Steffens DC; Ervin JF; Butterfield MI; Blazer DG; Massing MW; Lieberman JA
    Biol Psychiatry; 2006 Dec; 60(12):1287-94. PubMed ID: 16997284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage.
    Naylor JC; Hulette CM; Steffens DC; Shampine LJ; Ervin JF; Payne VM; Massing MW; Kilts JD; Strauss JL; Calhoun PS; Calnaido RP; Blazer DG; Lieberman JA; Madison RD; Marx CE
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3173-8. PubMed ID: 18477662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.
    Bernardi F; Lanzone A; Cento RM; Spada RS; Pezzani I; Genazzani AD; Luisi S; Luisi M; Petraglia F; Genazzani AR
    Eur J Endocrinol; 2000 May; 142(5):466-71. PubMed ID: 10802523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients.
    Weill-Engerer S; David JP; Sazdovitch V; Liere P; Eychenne B; Pianos A; Schumacher M; Delacourte A; Baulieu EE; Akwa Y
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5138-43. PubMed ID: 12414884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.
    Conejero-Goldberg C; Hyde TM; Chen S; Herman MM; Kleinman JE; Davies P; Goldberg TE
    J Alzheimers Dis; 2015; 48(4):969-78. PubMed ID: 26444771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopregnanolone and Pregnanolone Are Reduced in the Hippocampus of Epileptic Rats, but Only Allopregnanolone Correlates with Seizure Frequency.
    Lucchi C; Costa AM; Rustichelli C; Biagini G
    Neuroendocrinology; 2021; 111(6):536-541. PubMed ID: 32492675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol withdrawal-induced dysregulation of neurosteroid levels in plasma, cortex, and hippocampus in genetic animal models of high and low withdrawal.
    Jensen JP; Nipper MA; Helms ML; Ford MM; Crabbe JC; Rossi DJ; Finn DA
    Psychopharmacology (Berl); 2017 Sep; 234(18):2793-2811. PubMed ID: 28664280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise.
    Irwin RW; Brinton RD
    Prog Neurobiol; 2014 Feb; 113():40-55. PubMed ID: 24044981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory investigation of biomarker candidates for suicide in schizophrenia and bipolar disorder.
    Youssef NA; Bradford DW; Kilts JD; Szabo ST; Naylor JC; Allen TB; Strauss JL; Hamer RM; Brancu M; Shampine LJ; Marx CE
    Crisis; 2015; 36(1):46-54. PubMed ID: 25410258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
    Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
    J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma.
    Ahboucha S; Pomier-Layrargues G; Mamer O; Butterworth RF
    Neurochem Int; 2006 Sep; 49(4):372-8. PubMed ID: 16563564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
    Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
    Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels.
    Zhou JN; Liu RY; Kamphorst W; Hofman MA; Swaab DF
    J Pineal Res; 2003 Sep; 35(2):125-30. PubMed ID: 12887656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
    Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
    Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal expression of F-box and leucine-rich-repeat protein 2 decreases over Braak stages in the brains of Alzheimer's disease patients.
    Watanabe T; von der Kammer H; Wang X; Shintani Y; Horiguchi T
    Neurodegener Dis; 2013; 11(1):1-12. PubMed ID: 22455980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of pregnenolone sulphate, dehydroepiandrosterone and allopregnanolone in rat brain areas by liquid chromatography-electrospray tandem mass spectrometry.
    Rustichelli C; Pinetti D; Lucchi C; Ravazzini F; Puia G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 930():62-9. PubMed ID: 23727868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosteroids and self-reported pain in veterans who served in the U.S. Military after September 11, 2001.
    Kilts JD; Tupler LA; Keefe FJ; Payne VM; Hamer RM; Naylor JC; Calnaido RP; Morey RA; Strauss JL; Parke G; Massing MW; Youssef NA; Shampine LJ; ; Marx CE
    Pain Med; 2010 Oct; 11(10):1469-76. PubMed ID: 20735755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.